
News Release from HHS.gov: HHS Orders 2.5 Million More Doses of JYNNEO…
WATCH: FIRESIDE CHAT
with the ASPR, Dawn O'Connell, and BARDA Director, Dr. Gary Disbrow
Hear their vision on how ASPR & BARDA can assist in strengthening our medical countermeasure supply chains, manufacturing capacity and leveraging BARDA's innovation networks to prepare for future threats
The mission of the Biomedical Advanced Research and Development Authority (BARDA) is to develop medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases.
BARDA supports a number of core services to assist the development and production of required products, in a manner that is timely, reliable and cost effective.
Government Can Drive Innovation! At BARDA We Seek Innovation in Science…. and in the way we do business! BARDA has a long history of designing and launching innovative programs, to accelerate innovative ideas and deliver promising countermeasures to protect Americans.
The Pandemic and All Hazards Preparedness Act (PAHPA) established BARDA as the focal point within HHS for the advanced development of and acquisition of medical countermeasures to protect the American civilian population against CBRN and naturally occurring public health threats.
Rapid response to CBRN, pandemic influenza & emerging infectious disease threats requires a robust investment in diagnostics & devices across the spectrum of advanced research & development, stockpiling & domestic manufacturing capacity expansion.
BARDA uses a comprehensive portfolio approach to develop and acquire a broad array of medical countermeasures for pandemic influenza, including vaccines, therapeutics, diagnostics, and non-pharmaceutical countermeasures and to build and sustain their domestic manufacturing infrastructure.
DRIVe's mission is to accelerate the development and availability of transformative technologies and approaches to protect Americans from health security threats. DRIVe pushes innovation boundaries to tackle the biggest health security challenges while seeking new ideas and new approaches to prevent and protect against health security threats.
BARDA supports a number of core services to assist the development and production of required products, in a manner that is timely, reliable and cost effective.
Government Can Drive Innovation! At BARDA We Seek Innovation in Science…. and in the way we do business! BARDA has a long history of designing and launching innovative programs, to accelerate innovative ideas and deliver promising countermeasures to protect Americans.
The Pandemic and All Hazards Preparedness Act (PAHPA) established BARDA as the focal point within HHS for the advanced development of and acquisition of medical countermeasures to protect the American civilian population against CBRN and naturally occurring public health threats.
Rapid response to CBRN, pandemic influenza & emerging infectious disease threats requires a robust investment in diagnostics & devices across the spectrum of advanced research & development, stockpiling & domestic manufacturing capacity expansion.
BARDA uses a comprehensive portfolio approach to develop and acquire a broad array of medical countermeasures for pandemic influenza, including vaccines, therapeutics, diagnostics, and non-pharmaceutical countermeasures and to build and sustain their domestic manufacturing infrastructure.
DRIVe's mission is to accelerate the development and availability of transformative technologies and approaches to protect Americans from health security threats. DRIVe pushes innovation boundaries to tackle the biggest health security challenges while seeking new ideas and new approaches to prevent and protect against health security threats.